Aviado Bio in a $20M strategic equity deal with Astellas Pharma
02 October 2024
02 October 2024
Total investments received (USD): 115.69m
Round value (USD): 20m
Round investors:
Astellas Venture Management
Company: Aviado Bio
Related deals
Trimtech Therapeutics raised £25m in seed funding led by Cambridge Innovation Capital and SV Health Investors
Investments
02 March 2025
Latent Labs raised a $40 million Series A with Sofinnova Partners and Radical Ventures
Investments
03 February 2025
bit.bio raised $30 million post series B led by M&G Investments, joined by ARCH Venture Partners, BlueYard Capital, Milky Way, Puhua Capital, and Tencent
Investments
21 December 2024
Epitopea raised $31M in a pre-series A funding round with Investissement Québec, adMare BioInnovations, Jonathan Milner and existing investors
Investments
15 October 2024
Enara Bio raised $32.5m in Series B funding co-led by Pfizer Ventures and M Ventures, joined by RA Capital, Samsara BioCapital, and SV Health Investors.
Investments
03 September 2024
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain